CDIO - Cardio Diagnostics Holdings Inc
1.82
0 0%
Share volume: 30,670
Last Updated: 04-24-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.82
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-13-2024 | 03-20-2025 | 05-15-2025 | 11-12-2025 | 03-13-2026 | |
| Total revenue | 15.928 K | 7.870 K | 6.580 K | 4.512 K | 940.000 | 2.855 K | 3.555 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 15.928 K | 7.870 K | 6.580 K | 4.512 K | 940.000 | 2.855 K | 3.555 K | |
| -50.59% | -16.39% | -31.43% | -79.17% | 203.72% | 24.52% | |||
| Operating expenses | 4.135 M | 1.228 M | 1.359 M | 1.477 M | 1.544 M | 1.714 M | 82.902 K | |
| Selling general and admin | 4.124 M | 1.220 M | 1.353 M | 1.472 M | 1.542 M | 1.714 M | 82.902 K | |
| Research and development | 10.840 K | 7.280 K | 5.247 K | 5.758 K | 2.200 K | 0.000 | 0.000 | |
| Total expenses | 4.174 M | 1.290 M | 1.416 M | 1.521 M | 1.632 M | 1.714 M | 1.467 M | |
| -69.09% | 9.70% | 7.44% | 7.27% | 5.08% | -14.45% | |||
| Operating income | -4.158 M | -1.282 M | -1.409 M | -1.516 M | -1.631 M | -1.712 M | -1.463 M | |
| Ebit | -4.164 M | -1.288 M | -1.409 M | -1.505 M | -1.635 M | -1.715 M | -1.465 M | |
| Pretax income | -4.164 M | -1.288 M | -1.413 M | -1.519 M | -1.635 M | -1.715 M | -1.465 M | |
| -69.07% | 9.67% | 7.56% | 7.62% | 4.86% | -14.53% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.164 M | -1.288 M | -1.413 M | -1.519 M | -1.635 M | -1.715 M | -1.465 M | |
| 69.07% | -9.67% | -7.56% | -7.62% | -4.86% | 14.53% |